These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11545263)

  • 21. Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis.
    Ringer C; Weihe E; Schütz B
    Neurobiol Dis; 2012 Jan; 45(1):547-54. PubMed ID: 21964254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.
    Tu PH; Raju P; Robinson KA; Gurney ME; Trojanowski JQ; Lee VM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3155-60. PubMed ID: 8610185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A commentary on neuronal degeneration and cell death in Guam ALS and PD: an evolutionary process of understanding.
    Garruto RM
    Curr Alzheimer Res; 2006 Sep; 3(4):397-401. PubMed ID: 17017870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.
    Fulga TA; Elson-Schwab I; Khurana V; Steinhilb ML; Spires TL; Hyman BT; Feany MB
    Nat Cell Biol; 2007 Feb; 9(2):139-48. PubMed ID: 17187063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights from Drosophila models of Alzheimer's disease.
    Cowan CM; Shepherd D; Mudher A
    Biochem Soc Trans; 2010 Aug; 38(4):988-92. PubMed ID: 20658990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau protein and neurodegeneration.
    Kosik KS
    Mol Neurobiol; 1990; 4(3-4):171-9. PubMed ID: 2135393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA dysregulation in diseases of motor neurons.
    Ibrahim F; Nakaya T; Mourelatos Z
    Annu Rev Pathol; 2012; 7():323-52. PubMed ID: 22035195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis.
    Theunissen F; West PK; Brennan S; Petrović B; Hooshmand K; Akkari PA; Keon M; Guennewig B
    Transl Neurodegener; 2021 Nov; 10(1):46. PubMed ID: 34789332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.
    Rossi S; Bernardi G; Centonze D
    Exp Neurol; 2010 Jul; 224(1):92-102. PubMed ID: 20353778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau function and dysfunction in neurons: its role in neurodegenerative disorders.
    Avila J; Lim F; Moreno F; Belmonte C; Cuello AC
    Mol Neurobiol; 2002 Jun; 25(3):213-31. PubMed ID: 12109872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aged-related neurodegenerative diseases].
    Cruz-Sánchez FF
    Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(1):9-29. PubMed ID: 11188860
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro modelling of Alzheimer's disease: degeneration and cell death induced by viral delivery of amyloid and tau.
    Stoppelkamp S; Bell HS; Palacios-Filardo J; Shewan DA; Riedel G; Platt B
    Exp Neurol; 2011 Jun; 229(2):226-37. PubMed ID: 21295028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias.
    Trojanowski JQ; Lee VM
    Ann N Y Acad Sci; 1994 Dec; 747():92-109. PubMed ID: 7847694
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome.
    Cárdenas AM; Ardiles AO; Barraza N; Baéz-Matus X; Caviedes P
    Arch Med Res; 2012 Nov; 43(8):645-54. PubMed ID: 23142525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoskeletal alterations in the human tuberal hypothalamus related to argyrophilic grain disease.
    Schultz C; Koppers D; Sassin I; Braak E; Braak H
    Acta Neuropathol; 1998 Dec; 96(6):596-602. PubMed ID: 9845289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1103-10. PubMed ID: 17146283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders.
    Trojanowski JQ; Lee VM
    Ann N Y Acad Sci; 2000; 924():62-7. PubMed ID: 11193803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.